Please find below information relating to new and amended Pharmaceutical Benefits Scheme (PBS) listings implemented on 1st March 2024.

This information relates to the administration of these listings by Services Australia. For further information on broader PBS changes, please visit pbs.gov.au. Relevant information and authority application forms have been updated and can be accessed through the Services Australia website. 

Pre-symptomatic spinal muscular atrophy

Nusinersen (Spinraza®) (12 mg/ 5 mL intrathecal injection, 5 mL vial) has had a change to the restriction for the treatment of pre-symptomatic spinal muscular atrophy to include treatment of individuals with three copies of the survival motor neuron 2 gene. Authority applications for initial treatment can be made in writing. Authority applications for continuing treatment can be made either in real-time using the Online PBS Authorities system or by telephone.

Metastatic castration sensitive carcinoma of the prostate

Abiraterone (&) methylprednisolone (Yonsa Mpred®) (Pack containing abiraterone acetate 125 mg 120 tablets and methylprednisolone 4 mg 30 tablets) is now listed on the PBS for the treatment of metastatic castration sensitive carcinoma of the prostate. Authority applications can be made either in real-time using the Online PBS Authorities system or by telephone.

Chronic lymphocytic leukaemia or small lymphocytic lymphoma; mantle cell lymphoma

Ibrutinib (Imbruvica®) (280 mg tablet; 420 mg tablet; 560 mg tablet) has had three new medicinal product packs added to the existing 140 mg capsule product pack for the treatment of chronic lymphocytic leukaemia or small lymphocytic lymphoma; mantle cell lymphoma. Authority applications can be made either in real-time using the Online PBS Authorities system or by telephone.

Rheumatological conditions

Methotrexate (Methoblastin®, DBL Methotrexate®, Trexject®, Chexate®) (2.5 mg tablet; 10 mg tablet; injection 5 mg in 2 mL vial; injection 50 mg in 2 mL vial; injection 7.5 mg in 0.15 mL pre-filled syringe; injection 10 mg in 0.2 mL pre-filled syringe; injection 15 mg in 0.3 mL pre-filled syringe; injection 20 mg in 0.4 mL pre-filled syringe; injection 25 mg in 0.5 mL pre-filled syringe) has had a change to the restriction to include nurse practitioners as eligible prescribers.

Chronic heart failure

Dapagliflozin (Forxiga®) (10 mg tablet) is now listed on the PBS for the treatment of chronic heart failure where the patient has a left ventricular ejection fraction of greater than 40%. Prescriptions for treatment are Authority Required (STREAMLINED).

SARS-CoV-2 infection

Molnupiravir (Lagevrio®) (200 mg capsule) and nirmatrelvir (&) ritonavir (Paxlovid®) (nirmatrelvir 150 mg tablet (&) ritonavir 100 mg tablet) have had amendments to the existing listings for the treatment of SARS-CoV-2 infection. Prescriptions for treatment are Authority Required (STREAMLINED).

Severe pain

Hydromorphone hydrochloride (pms-HYDROmorphone®) (1 mg/mL oral liquid, 500 mL) for the treatment of severe pain is now listed on the PBS for the current supply shortage under Section 19A. Hydromorphone is listed as an Authority Required (STREAMLINED) benefit and as a restricted benefit.

Morphine hydrochloride trihydrate (Morphini HCl Streuli®) (10 mg/mL oral liquid, 20 mL) for the treatment of severe pain is now listed on the PBS for the current supply shortage under Section 19A. Morphine is listed as an Authority Required (STREAMLINED) benefit and as a restricted benefit.

For more information about the Online PBS Authorities system visit www.servicesaustralia.gov.au/hppbsauthorities.

Services Australia has a broad range of educational resources on the Health Professional Education Resources website. This includes simulations, podcast and an infographic on the Online PBS Authorities system. Visit https://hpe.servicesaustralia.gov.au/pharmaceutical-benefits-scheme.html.

Visit servicesaustralia.gov.au/hpwrittenauthoritydrugs on the Services Australia website to find the most up to date authority application form for each drug, program or condition.

For more information go to servicesaustralia.gov.au/hpos.

To learn more about these updates, please contact Services Australia directly.

At Practice Managers Australia, we support Practice Managers in both staff recruitment and retention, and ensure that our service and advice is tailored to your specific goals to promote growth and flourishing.

Follow our LinkedIn and Facebook pages for more information.